San Francisco-based data analysis and management platform DNAnexus announced Tuesday that it raised $100 million in a Series G financing round co-led by Perceptive Advisors and Northpond Ventures.
The cloud-based SaaS company was created to service life scientists around the world by aiding research efforts and making research data more accessible. The suite of cloud-based services offered by the company provides computer-based infrastructure vital for the completion of DNA sequencing processes.
According to the company, its health informatics platform also serves as a collaborative environment where genomics, multi-omics and real world data can be combined with clinical data at scale.
“The next wave of biomedical insights and treatments will be driven by large-scale clinical ... and real world data resulting from cross-institutional collaborations,” Richard Daly, CEO of DNAnexus, said in a statement.
The platform aims to ease research processes for those who work in the healthcare industry and beyond by providing clients with data that can result in improved diagnostics, better patient care and alternative therapy options.
“The trend toward cloud-based data analysis and collaboration is accelerating, and we are at the right place at the right time to future-proof and serve our customers,” Daly continued.
According to the company, its network supports some of the largest human genome sequencing projects in the world. The latest round will be used to further expand the global reach of the machine learning platform. According to Daly, the platform has seen increased use of its virtual cloud workspace service due to COVID-19.
Existing investors GV, Foresite Capital, TPG Capital and First Round Capital also participated in the round. DNAnexus is headquartered in Mountain View with additional offices in San Francisco, Prague and London.
The company has raised a total of $172.6 million in venture capital to date, according to Crunchbase.
